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a b s t r a c t
E-twenty six variant 2 (Etv2) transcription factor participates in cardiac, vascular-endothelial and blood
cell lineage speciﬁcation decisions during embryonic development. Previous studies have identiﬁed
genomic elements in the etv2 locus responsible for vascular endothelial cell speciﬁcation. Using
transgenic analysis in zebraﬁsh, we report here an etv2 proximal promoter fragment that prevents
transgene misexpression in myocardial progenitor cells. This inhibition of etv2 expression in the cardiac
progenitor population is partly mediated by Scl and Nkx2.5, likely through direct binding to the etv2
promoter, and cis-regulatory elements located in the ﬁrst and second introns. The results identify an etv2
cis-regulatory mechanism controlling cardiovascular fate choice implying that etv2 participates in a
transcriptional network mediating developmental plasticity of endothelial progenitor cells during
embryonic development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
During vertebrate embryonic development, cells of the cardiac,
blood and vascular lineages are speciﬁed from lateral plate
mesoderm (LPM) via integration of inductive signals and systema-
tic activation and deactivation of transcriptional programs in
progenitor cells. Cardiac development in particular is orchestrated
by a unique set of transcription factors that include Gata5, Hand2
and Nkx2.5. Stem cell like (Scl) and E26 transformation-speciﬁc
domain (Ets) variant 2 (Etv2) factors have recently been added to
this list. Speciﬁcally, scl represses cardiomyogenesis in prospective
hemogenic endothelium and endocardium (Van Handel et al.,
2012), and etv2 function is necessary for repression of cardiac fate
in putative endothelial-fated precursor cells (Palencia-Desai et al.,
2011) suggesting the existence of a common progenitor cell of
cardiac, blood and vascular lineages. Further support to this
concept comes from a report showing a genetic link between
hemangioblast and cardiac development (Peterkin et al., 2009).
Endothelial, cardiac and blood precursor cells all arise in the
anterior LPM shortly after gastrulation, and over the course of
development, speciﬁcation into each lineage occurs as distinct sets
of transcription factors are silenced or activated. Factors Scl and
Lmo2 are involved in hemangioblast development from anterior
LPM (Patterson et al., 2007), and Hand2 and Nkx2.5 transcription
factors (Thattaliyath et al., 2002) are essential for cardiac cell
speciﬁcation from LPM cell pools. Nkx2.5 and nkx2.7 genes play an
essential role in maintaining ventricular and atrial cardiomyocyte
identity (Targoff et al., 2013), and in establishing gene expression
borders between cardiac cell lineages during heart development
(Nakashima et al., 2014). Similar to Nkx2.5, Etv2 has also been
recently implicated in cardiomyocyte development (Palencia-
Desai et al., 2011). Because Etv2 appears to function at the
interface of hematopoietic, vascular and cardiac lineage speciﬁca-
tion, we hypothesized that examination of etv2 gene regulation
will reveal mechanisms involved in the differentiation of sub-
populations of blood, endothelial and cardiac cells from anterior
LPM in zebraﬁsh. Two studies (Proulx et al., 2010; Veldman and
Lin, 2012) have already identiﬁed genomic fragments that control
tissue-speciﬁc etv2 expression during zebraﬁsh embryonic devel-
opment. Proulx et al. reported elements in the etv2 genomic locus
responsible for vascular-speciﬁc expression. Veldman et al. identi-
ﬁed a 110 bp upstream enhancer of etv2 that contains a functional
binding site for Foxc1a and Foxc1b factors responsible for vascular-
speciﬁc etv2 expression. Here, by using transgenic reporter analy-
sis of the etv2 genomic locus, we identiﬁed cis-regulatory ele-
ments that are responsible for the transcriptional repression of the
etv2 gene in precursors of endocardial and myocardial cells. Using
morpholino oligonucleotide-mediated knockdowns, we found that
Scl and Nkx2.5 transcription factors participate in this repression
mechanism. Cardiac inhibition of etv2 expression is likely through
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sequence-speciﬁc binding of Scl to the etv2 promoter as shown in
a protein-DNA interaction assay. Moreover, using a dual-luciferase
reporter system, we identiﬁed cis-regulatory elements located in
the ﬁrst two introns of etv2. Together, our studies reveal evidence
for developmental plasticity of a progenitor cell of endothelial,
endocardial and myocardial lineages that responds to etv2 expres-
sion modulation during embryonic cardiovascular development.
Material and methods
Generation of transgenic zebraﬁsh lines
Approximately 1 nL of each construct c1, c2 and c3 was micro-
injected into zebraﬁsh zygotes at a ﬁnal concentration of 25 ng/μL
together with 25 ng/μL in vitro-transcribed transposase mRNA from
NotI-linearized pCS2FA-transposase plasmid in 0.1% phenol red
using a gas-driven microinjector (World Precision Instruments PV
820). Constructs c4, c5 and c6 were co-injected with I-SceI mega-
nuclease (NEB). See Supplemental Experimental Procedures for
construct cloning and analysis of transgenic lines (Table S1). All
animal experiments were performed in accordance with guidelines
and protocols (AUA 320) approved by the Institutional Animal Care
and Use Committee at the Medical College of Wisconsin.
Whole-mount in situ hybridization (ISH)
Chromogenic detection of endogenous and transgenic transcripts
(regular ISH) was conducted as described previously (Thisse and
Thisse, 2008). Two-color ﬂuorescent in-situ-hybridization (FISH) was
performed with modiﬁcations described in the Supplemental
Experimental Procedures section.
Imaging
Confocal z-stacks of stained specimen were acquired using an LSM
510 confocal microscope system (Zeiss). 3D images were recon-
structed, processed and analyzed with Volocity 6.0.1 software (Per-
kin-Elmer). Quantiﬁcation of colocalization was performed using raw
z-stack data in Volocity. Mred and Mgreen values correspond to
colocalization coefﬁcients M1 and M2 in a region of interest (ROI),
with M1 describing the percentage of all red pixels colocalizing with
green pixels, and M2 the percentage of all green pixels colocalizing
with red pixels in an ROI (Zinchuk et al., 2007). R is the overlap
coefﬁcient according to previous studies (Manders et al., 1993). Back-
ground corrected ROIs (schematically indicated by blue dashed circles
in Fig. S4) resulted in thresholded scatter plots ensuring reliability of
colocalization and overlap coefﬁcient calculations in Volocity.
Morpholino antisense oligonucleotides
Previously published and efﬁcacy validated morpholinos for
knockdown of nkx2.5 (Goldstein and Fishman, 1998), gata5
(Holtzinger and Evans, 2007), hand2 (Trinh et al., 2005), scl
(Gering et al., 1998) and etv2 (Sumanas and Lin, 2006) were
purchased from GeneTools, LLC, Philomath, OR, USA, and recon-
stituted in water to 2 mM stock concentration. Approximately 1 nL
of injection mix containing 0.1% phenol red was microinjected into
zebraﬁsh zygotes. Sequences and doses used are given in the
Supplemental Experimental Procedures section.
Luciferase assays
Fragments for cloning of zebraﬁsh etv2- and myl7-based reporter
constructs were PCR-ampliﬁed from p5E-3114 (see Supplemental
Experimental Procedures) and BAC clone Ch211-87L2 (BACPAC
Resources Center, Oakland, CA, USA), respectively. To amplify ampi-
cillin/kanamycin coding sequence serving as replacements for etv2
downstream sequence, TOPO-cloning vector pCR2.1 (Life Technolo-
gies) was used as template. Fragments with 15 bp overlapping
sequence were PCR-ampliﬁed, and were cloned into the EcoRV-
linearized pGL4.14 ﬁreﬂy Luciferase vector (Promega) using the In-
Fusion cloning kit (Clontech) according to the manufacturer's recom-
mendations. Constructs were phenol–chloroform-extracted, ethanol-
precipitated, sequence-veriﬁed, and used for zebraﬁsh microinjections
and H9C2 rat embryonic myocardium cell (ATCC, no. CRL-1446)
transfections. For microinjections, respective ﬁreﬂy constructs and
Renilla luciferase control reporter vector pRL-TK (Promega) were
mixed at 66 and 33 ng/μL ﬁnal concentrations, respectively, con-
taining 0.1% phenol red, and 100–150 pg total DNA were injected
into zebraﬁsh zygotes. Forty embryos were dechorionated by
pronase (Sigma P5147) treatment, deyolked (Link et al., 2006) and
lysed in 100 μL passive lysis buffer (Promega) at 6 and 22 somite
stages. For H9C2 cell transfections, 10,000 cells per well were
seeded in 24-well plates and grown for 48 h at 37 1C and 5% CO2
in complete medium composed of DMEM, 20% Hi-FBS and 1%
penicillin/streptomycin (Life Technologies). Transfection mixes con-
tained 40 μL serum-free medium, 5 μL H9C2 transfection reagent
(Altogen Biosystems), 56 fmol Renilla control vector and 51 fmol
respective ﬁreﬂy construct DNA in 49 μL total volume. Transfection
mixes were incubated for 30 min at room temperature to allow for
transfection complex assembly, then added to the cells in 500 μL
fresh complete medium, and incubated for another 48 h. Luciferase
expression measurements from both microinjections and cell
transfections were executed in technical triplicates from three
independent experiments using the Dual-Luciferase Reporter 1000
Assay System (Promega) in a GLOMAX 20/20 luminometer (Pro-
mega) according to the manufacturer's instructions.
Electromobility shift assay (EMSA)
Recombinant zebraﬁsh Scl and Tcf3 (E12/E47) proteins were
produced using the TNT™ T7 Quick for PCR DNA kit (Promega,
Madison, WI, USA) according to the manufacturer's recommenda-
tions. Primer sequences for generation of template-DNA in TNT
reactions, western blot and binding conditions are given in the
Supplemental Experimental Procedures section.
Statistics
To assess the “goodness of ﬁt” of distributions of (trans)gene
expression magnitudes from categorized embryo numbers in
morpholino knockdown experiments, exact 2-sided p-values were
calculated using StatXact™ 8 software (Cytel Inc., Cambridge, MA,
USA) applying Pearson's Chi-square and Fisher's Exact tests when
needed. Statistical signiﬁcance in luciferase assays was calculated
using t-tests (two-tailed, unpaired) in Excel 2008 software (Micro-
soft) from three independent experiments with three technical
replicates each. All error bars represent standard deviations.
Statistically signiﬁcant data with p-values r0.05 and r0.01 are
marked in the ﬁgures by n and nn, respectively. Statistically high
signiﬁcant data (pr0.001) are marked by nnn. The Results section
text includes calculated p-values.
Results
Etv2 genomic locus characterization
Our laboratory has previously identiﬁed that etv2þ cells at the
lateral plate mesoderm (LPM) in zebraﬁsh proliferate prior to
migration to the midline during vasculogenesis (Chun et al., 2011).
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To investigate the transcriptional regulation of etv2, we performed
bioinformatic analyses to identify genomic elements that direct
the vascular speciﬁc expression of etv2 during embryonic devel-
opment. Etv2 and ﬂi1, a second transcription factor with vascular
function (Brown et al., 2000; Pham et al., 2007) are juxtaposed in
opposite orientations on chromosome 16 with a space of approx.
4.1 kb distance between respective ﬁrst exons separating the two
genes (Fig. S1A). Bioinformatic analysis showed two conserved
regions in this interspersed genomic DNA, an upstream (3.1 to
1.8 kb relative to TSS) and an intronic (þ0.4 to þ0.8 kb relative
to TSS) region (up1 and int2 in Fig. S1A). We initially generated a
series of constructs (Fig. 1A) encompassing these two regions
fused to ﬂuorescent proteins (Kaede, mCherry or EGFP) in Tol2- or
I-Sce I vector-based transgenesis systems. While our study was
ongoing, a second independent study by Veldman and Lin (2012)
published a putative 2.3 kb etv2 promoter element. In that study,
they narrowed down the 2.3 kb promoter to a conserved 110 bp
region (up1) that was sufﬁcient for vascular expression at 24 hpf.
This region along with more upstream and another conserved
intronic (int2) region described before Veldman and Lin (2012)
were suggested to be responsible for driving robust etv2 expres-
sion during development. Our analysis indicates that 5.1 kb, 4.1 kb,
3.2 kb and 3.1 kb etv2 genomic fragments (Fig. 1A, constructs c1,
c5, c4 and c2, respectively), all containing both at least 2.17 kb
upstream and downstream (encompassing exon 1 to intron 2)
regions (Veldman and Lin, 2012) consistently showed vascular-
endothelial expression. We performed ISH for the transgenes in
these lines (Fig. 1B). The 5.1 kb, 4.1 kb and 3.2 kb transgenic lines
showed vascular expression of the reporter gene with minimal
ectopic expression during late somitogenesis and early primordial
stages (Fig. 1B, constructs c1, c5 and c4). Surprisingly, robust
vascular transgene expression pattern was also observed in trans-
genic lines generated from construct c6, which differed from
constructs c1, c2, c4 and c5 by a truncated upstream region
(0.6 kb, Fig. 1A). This result, in contrast to results from the Veld-
man study (Veldman and Lin, 2012), indicated that most if not all
distal promoter sequence is dispensable for vascular-speciﬁc
expression of etv2. Constructs 2 (c2) and 3 (c3) both contain the
same upstream region (2.17 kb relative to TSS), but c3 lacks the
downstream region encompassing exons 1 and 2 and introns 1 and
2 (Fig. 1A). In the c2 transgenic lines (Fig. 1B), we noticed that most
aspects of vascular expression such as head, axial, and intersomitic
vessels are present. Moreover, all transgenes harboring the down-
stream intronic region recapitulated the endocardial etv2 expres-
sion domain (shown here for c2, marked by white arrows in
Fig. 1C). Strikingly, deleting downstream intronic sequence (c3)
resulted in ectopic transgene expression in tissue surrounding the
endocardial domain, which represents the myocardial domain of
the embryonic heart (dotted circle in Fig. 1C, c3). This pattern
change was observed consistently in all independent transgenic
lines generated from c3. Further, expression in the developing
vasculature was reduced with few cells in the caudal plexus
showing expression (Figs. 1B, c3). Also, head and axial vessel
expression was restricted compared to transgenic lines derived
from constructs that contain downstream intronic sequence.
Taking all these data together, we conclude that etv2 promoter
fragments comprising the downstream intronic region harbor the
regulatory elements responsible for repressing myocardial expres-
sion, and maintaining endocardial and vascular expression of etv2
during embryonic vascular development. Table S1 summarizes the
expression patterns of the transgenes.
Transgene expressing cells in the downstream fragment-deleted c3
transgenic line change from endothelial/endocardial to myocardial
expression patterns during somitogenesis
Since the majority of the Veldman and Lin (2012) work focused
on the up2 element, we have restricted our analysis here to the
Fig. 1. Overview on transgenic construct designs and expression patterns: (A) Constructs c1–c6 contained different fragments of the etv2 locus on chromosome 16 ranging
from inclusion of the whole non-coding 4164 bp etv2–ﬂi1b intergenic region (blue) plus the ﬁrst and second exon–intron pair (purple) downstream of the transcription start
site (TSS) fused to cDNA of ﬂuorescent reporter protein mCherry in c1, a shorter 2170 bp upstream fragment plus the downstream region fused to egfp cDNA in c2, and a
2170 bp upstream fragment without the downstream exon–intron pair fused to kaede coding sequence in c3. Construct c4 contained a 100 bp more upstream sequence than
c2 including the FOXC binding site (black asterisks) described by Veldman and Lin (2012), and c5 and c6 contained 3108 bp and 602 bp upstream sequences, respectively. c4–
c6 also included the downstream region (equivalent to c1 and c2), and was fused to the egfp reporter. All constructs c1–c6 contained a polyadenylation signal (pA) at the 30
end. (B) Expression patterns of c1–c6 in stable transgenic embryos around 1 dpf (25 som to prim 8 stages) were revealed by ISH. Representative embryos are oriented
laterally with the head to the left. All transgenes showed robust vascular expression in head and axial vessels and the vascular plexus region recapitulating the endogenous
etv2 expression pattern except for c3, which showed vascular plexus expression but reduced axial and head vessel expression. (C) At 20–22 som, endogenous etv2 expression
is present in the endocardial domain of the developing cardiac disc, which was recapitulated by the c2 egfp reporter (white arrows). In contrast, the c3 kaede reporter was
expressed in the myocardial domain of the early heart (white dashed circle). Embryo views are dorsal with the head to the top.
M.-O. Schupp et al. / Developmental Biology 393 (2014) 71–83 73
downstream intronic element (int2). The int2 element is highly
conserved across ﬁsh species, and some homology to human
sequence was detected as well (Fig. S1B). To determine spatial
differences in the co-expression of c2 (intron-containing) and c3
(intron-less) transgenes with vascular-endothelial and heart mar-
kers, we focused on the anterior LPM expression at 6–8 som and
on cardiac expression at 20–22 som (Fig. 2), stages most relevant
to cardiac precursor cell development in zebraﬁsh (Schoenebeck et
al., 2007). At 6–8 som, we performed comparative ﬂuorescent ISH
analysis of the c3 intron-less transgene with the endogenous etv2
gene (Fig. 2), as well as cardiac markers nkx2.5, hand2 and gata5
and blood marker scl (Fig. S2). At 6–8 som, most if not all
transgene expressing cells is etv2-positive (þ) indicating a high
level of recapitulation of the endogenous expression pattern by
the c3 transgene (Fig. 2A C). Scl also co-localized well with the c3
transgene at this stage (Fig. S2A–C), while anterior hand2þ cells
showed minimal if any c3 transgene activity (Fig. S2D F), and for
nkx2.5, no overlap with transgene expression could be detected at
the anterior LPM at 6–8 som (Fig. S2G I). Later at 20–22 som
(Fig. 2), in the c3 (intron-less) transgenic line, ectopic reporter
expression in the cardiac disc showed no overlap with endogenous
etv2 expression (Fig. 2D–F), whereas in the c2 (intron-containing)
line, reporter expression maximally matched the etv2 expression
pattern (Fig. 2G–I). The ectopic cardiac expression domain of c3
was identiﬁed as the myocardial precursor cell population co-
expressing nkx2.5 (Fig. S2J–L) and myosin light polypeptide 7 (myl7,
formerly known as cardiac myosin light chain 2, Fig. S2M–O).
Interestingly, co-localization of the c3 transgene with endogenous
etv2 in the cardiac disc (endocardial domain) appears minimal
compared to the c2 transgene (compare Fig. 2F and I, white arrow
indicates etv2þ endocardial cells in the center of the cardiac disc
surrounded by myocardial, nkx2.5þ cells). In most cases, no signal
for the c3 transgene transcript was detected in the endocardial
domain (e.g. Fig. S2K, N, Q; see also Fig. 1C, c3 and Fig. 3A). Of note,
we observed a general decrease in c3 transgene expression over
generations such as the signal in the anteriorly located head
vessels became silenced in F5 embryos (Fig. S2N) although still
present in F2 embryos (Fig. 2E and Fig. S2K, Q). The transgene
expressing cells co-localized with the gata5þ mesodermal (myo-
cardial) expression domain (encircled in Fig. S2P), whereas the
ﬂanking endodermal domains of gata5 (stars in Fig. S2P) were
clearly negative for c3 transgene expression (Fig. S2R). In the c2
(intron-containing) transgenic line, however, transgene expression
did not overlap with gata5 in the myocardium (Fig. S2S–U). In
contrast, c3 transgene expression was persistent in the zebraﬁsh
heart after 40 hpf (Fig. S3A) and 64 hpf (Fig. S3B). The transient
presence of c2 transgene mimics the endogenous etv2 transcripts,
which was hardly detectable after 36 hpf (Sumanas and Lin, 2006).
This indicated a temporal misregulation of the c3 transgene in
addition to the observed spatial differences in its expression.
Summarizing the ISH data at 6–8 and 20–22 som in the two
transgenic lines (c2 and c3) suggests that during development,
both transgenes are expressed for the most part in etv2 expressing
cells at early somitogenesis stages, but post the 8 som stage, the
expression of the c3 transgene localizes to myocardial progenitor
cells. These data also suggest differential regulation of etv2
expression in different cell types post early patterning events in
the vertebrate embryo.
Changes in downstream fragment-deleted c3 transgene expression
following knockdown of cardiac-speciﬁc transcription factors
Because putative etv2 cis-regulatory sequence contains bioin-
formatically predicted binding sites for several heart-related
transcription factors (Fig. S1C), we knocked down each of these
factors, and performed ISH for the intron-less c3 transgene to
Fig. 2. The c3 intron-less reporter recapitulates endogenous etv2 expression pattern during early but not late segmentation stages. Two-color ﬂuorescent ISH of c3
transgenic embryos at 6–8 som in the ALPM (A–C) and at 20–22 som in the cardiac disc (D–F) for the detection of endogenous transcripts of etv2 in red (A and D) and
concomitant detection of kaede transcripts from the c3 transgene in green (B and E), merged in (C and F). At 6–8 som, maximal overlap of both signals was observed (C),
however at 20–22 som, cardiac c3 transgene expression did not overlap with endogenous etv2 (F) whereas the c2 egfp transgene recapitulated etv2 expression at that stage
(G and H). Embryos are dorsal with anterior to the top. Images shown are snapshots from 3D views with bars E100 μm related to the background grid (1 unit¼45.18 μm in
A–C, 22.59 μm in D–F, and 22.54 μm in G–I).
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investigate changes in its expression level at 6–8 and 20–22
somite stages. We hypothesized that knocking down one or
combinations of these factors would result in changes in transgene
expression magnitude in the heart in the c3 transgenic line.
Efﬁcacy conﬁrmed and validated morpholinos previously used in
the zebraﬁsh ﬁeld (Patterson et al., 2005; Reichenbach et al., 2008;
Sumanas and Lin, 2006; Targoff et al., 2008; Trinh et al., 2005)
were microinjected into zygotes, and ISH was performed to reveal
transgene expression at 6–8 som (Fig. S3A and B), and 20–22
somite stages (Fig. 3). Independent transgenic c3 ﬁsh were mated
with wild type ﬁsh to obtain quantiﬁable numbers of transgenic
zygotes for injection. Different mating pairs generated embryos
with varying transgene magnitudes most likely resulting from
differences in transgene copy number genomic integration events.
Following pooling and equal division of progeny of several mating
pairs of independent c3 transgenic lines from different genera-
tions, we determined and counted the magnitude categories of
transgene expression in embryos injected with either target-
speciﬁc or non-targeting standard control morpholinos (MOs).
The MOs were titrated to ensure that the reductions in respective
gene expression levels did not result in morphologically obvious
phenotypes such as absence of beating hearts in nkx2.5morphants
or absence of circulating blood cells in scl and etv2 morphants.
Transgene expression magnitudes were categorized by visual
assessment (very strong, strong, medium, weak, absent, or trans-
gene negative). We scored numbers and show representative
images of transgene expression categories at the respective
embryonic stages (6–8 som and 20–22 som). Structure (anterior
Fig. 3. Changes in intron-less c3 transgene versus intron-containing c2 transgene expression magnitudes in the cardiac disc in response to single and combined knockdowns
of key myocardial (gata5, nkx2.5) and endocardial/endothelial (scl, etv2) transcription factors. (A) Representative embryos post ISH showing four categories of c3 transgene
expression magnitudes in the myocardial domain of the cardiac disc (blue frame) with transgene expression categories scored and quantiﬁed in (B1–5). Knockdown of nkx2.5
resulted in an increase, knockdown of gata5 in a decrease of c3 transgene expression (B1). Knockdown of scl also lead to an increase (B2), etv2 morphants however showed
no signiﬁcant change in c3 transgene expression (B3). Combined knockdown of scl and etv2 (B4) or nkx2.5 and etv2 (B5) again resulted in an increased c3 transgene
expression indicating that scl and nkx2.5 (but not etv2) cooperate in c3 repression. (C–D) Combined knockdown of scl and nkx2.5 compared to single knockdowns showing
cardiac disc expression categories of the c3 transgene in representative embryos (C) and quantiﬁcation (D). Note that combined scl and nkx2.5 knockdown resulted in an
additional category of “very strong” c3 transgene expressing embryos not seen in single knockdowns indicating synergism of scl and nkx2.5 in c3 transgene repression.
(E) Representative embryos showing categories of c2 transgene expression in the endocardial domain of the cardiac disc following single knockdowns of scl and nkx2.5 and
quantiﬁcation in (F). (G) Combined knockdown of scl and nkx2.5 showing cardiac disc expression categories of the c2 transgene in representative embryos and quantiﬁcation
in (H). Note that single nkx2.5 knockdown resulted in signiﬁcant change in c3 but not c2 transgene expression (compare D and F). Embryos shown are at 20–22 som stages in
dorsal view with anterior to the top. *** indicates pr0.001; ** indicates pr0.01; * indicates pr0.05; n.s.¼not signiﬁcant (p40.05); n.d.¼not detected; MO¼morpholino;
n¼number of scored embryos; blue frame marks the endocardial cardiac disc expression domain of the c2 transgene. Categories of transgene expression magnitudes scored
are color-coded in (B, D, F and H). Pooled F2 and F3 generations of two transgenic c3 lines were analyzed in A/B, and pooled F5 and F2 generations of 2 lines in C/D. F4
generation embryos of two c2 lines were analyzed in E–H.
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LPM, cardiac disc) and number of embryos (n) showing the
respective category of transgene expression is provided in a
color-coded percent format (number of embryos in each category
divided by total number of embryos) for a given experiment.
At 6–8 som, loss-of-function (LOF) analysis using MOs that
target nkx2.5 (Fig. S3B, p¼0.22), gata5 (Fig. S3B, p¼0.55), scl
(Fig. S3B, p¼0.86), or hand2 (Fig. S3B, p¼0.71) showed no
signiﬁcant changes in c3 transgene expression in the anterior
LPM. At 20–22 som, we investigated transgene expression in the
cardiac disc (marked by blue frame in Fig. 3A) following knock-
down of heart- and vascular-speciﬁc transcription factors. Com-
pared to embryos injected with standard control MO, nkx2.5 and
gata5 knockdowns resulted in polar opposite changes in c3
transgene expression in that knockdown of nkx2.5 lead to sig-
niﬁcantly greater number of morphants with strong transgene
expression (Fig. 3B1, strong, p¼2.231e-006, n¼93), and knock-
down of gata5 showed greater number of morphants with weak
transgene expression (Fig. 3B1, weak, p¼0.0003, n¼96) in the
cardiac domain. In case of scl and etv2, single scl knockdown
resulted in a greater number of morphants with strong transgene
expression (Fig. 3B2, p¼0.007, n¼109), and etv2 morphants
showed no relevant change (Fig. 3B3, p¼0.54, n¼94). Knocking
down etv2 and scl together resulted in more morphants with
strong c3 transgene expression in the cardiac disc (Fig. 3B4,
p¼0.004, n¼92) indicating that scl but not etv2-regulated c3
expression here. For nkx2.5 and etv2 double knockdown, we
observed signiﬁcant higher percentage of morphants with strong
transgene expression in the cardiac domain (Fig. 3B5 and S3A,
p¼2.047e-005, n¼29), conﬁrming that nkx2.5 regulated the
majority of c3 expression. Besides from increased cardiac c3
expression, these morphants showed a concomitant increase in
transgene expression in anterior head vessel progenitors (Fig. S4B,
p¼1.671e-012). In contrast, c3 expression in more posteriorly
located trunk vessel progenitors were not signiﬁcantly changed
(Fig. S4C, p¼0.602). This indicated that the de-regulated c3
transgene was inhibited by nkx2.5 in ALPM- but not PLPM-
derived cardiac and endothelial progenitor populations, Since
nkx2.5 is not expressed by the EC lineage, this suggests a non-
cell autonomous role for nkx2.5 in of angioblast development.
These data collectively suggest that scl and nkx2.5 function
together in repressing transgene expression in the cardiac disc in
the c3 transgenic lines at 20–22 som, while gata5 seems to
antagonize the function of these genes.
Scl and nkx2.5 function together to repress transgene expression in
intron-less and intron-containing transgenic lines
To conclusively determine the roles of scl and nkx2.5 in
regulating transgene reporter activities, we knocked down scl
and nkx2.5 together in both c3 (Fig. 3C and D) and c2 (Fig. 3E
and H) transgenic lines. In c3 intron-less lines, we observed the
appearance of an additional category of “very strong” transgene
expressing morphants (Fig. 3C) and an increase in strong trans-
gene expressing morphants compared to either transcription
factor alone (Fig. 3D, p¼0.0002 and 0.001 compared to nkx2.5
and scl single knockdowns, respectively), which was consistent
with our earlier analysis, and indicated synergism of scl and nkx2.5
in c3 transgene inhibition. In the c2 intron-containing line, we
similarly observed that scl and nkx2.5 double knockdown showed
a more signiﬁcant increase in the number of very strong (Fig. 3G
and H, p¼5.677e-014, n¼81) transgene expressing morphants
compared to single scl knockdown (Fig. 3E and F, p¼1.043e-006,
n¼163). Interestingly, we noticed that nkx2.5 knockdown alone
showed signiﬁcant increase in c3 (Fig. 3D, p¼2.746e-007, n¼176),
but not c2 transgene expression (Fig. 3F, p¼0.58, n¼128) when
compared to control morphants, suggesting participation of etv2
downstream sequence in nkx2.5-mediated inhibition of c2 trans-
gene expression.
Note that the distributions of reporter expression magnitudes
in the control morphants differ across experiments because
clutches from different independent transgenic lines per construct
were pooled. This approach, combined with high embryo numbers
per sample, maximized normalization of transgenic expression
magnitudes across samples per experiment before injection and
thus ensuring quantitation. To further ensure objective quantiﬁca-
tion of changes in transgene magnitudes in knockdown experi-
ments, we performed two independent blinded embryo counts on
wells containing single and combined nkx2.5/scl morphants at the
22 somite stage after MO injections and ISH detecting c3 transgene
expression magnitudes (Fig. S5). According to the embryo num-
bers obtained for each category of cardiac transgene staining
intensity, we were able to identify respective morphants based
on previous results (Fig. 3). For example, embryos in well #3 were
clearly identiﬁable as double scl/nkx2.5 morphants. Therefore, the
results and conclusions are afﬁrmed in an objective test
assessment.
We also performed two-color ﬂuorescent ISH to investigate the
spatial changes in c2 and c3 transgene expression in morphant
cardiac discs following digital 3D reconstruction (Fig. 4). In control
morphants, cardiac expression of the intron-less c3 transgene
localized to both endocardial and myocardial domains and
matched myl7 expression maximally (Fig. 4A–C). In contrast,
intron-containing c2 transgene transcripts were present in the
myl7-endocardial progenitor cell population (Fig. 4M–O, medially
located endocardial cells are marked by a dashed circle in Fig. 4N).
Upon knockdown of scl, increased endocardial expression of both
c3 (Fig. 4D–F) and c2 (Fig. 4P–R) transgenes were observed
indicating that de-repression of etv2 expression caused an accu-
mulation of endocardial precursors. Note the compaction of scl
morphant cardiac discs in transverse optical sections as given in
the insets of merged images (Fig. 4R). This phenotype was
consistent with observations in scl/tal1 mutant zebraﬁsh where
increased cdh5 expression in aggregated endocardial precursors
caused defective migration and disturbed anterior closure of the
circular myocardium surrounding the endocardium (Bussmann et
al., 2007). In nkx2.5 morphants, we noticed an approximate 20%
reduction in size of the myl7þ expression domain (Fig. 4G and S).
Consistent with the quantitation of c3 transgene expression in
nkx2.5 knockdown embryos (Fig. 3D), we observed spatial expan-
sion of c3 transgene expression domain (Fig. 4H–I), further
supporting the concept that loss of nkx2.5 function resulted in a
change of myocardial towards a more endothelial identity of these
cells responding with increased expression of the etv2 sequence-
based reporter transgene. In contrast, endocardial precursors were
unaffected by loss of nkx2.5 function since cardiac c2 transgene
expression was unchanged (Fig. 4S–U). Combined knockdown scl
and nkx2.5 resulted in a combined increase in c3 transgene
expression in both myo- and endocardial progenitor domains
(Fig. 4J–L). c2 Transgene expression was increased in endocardial
cells as in scl single knockdown embryos, however when nkx2.5
was knocked down concomitantly (Fig. 4V–X), myl7þc2 transgene
co-expressing cells were also detected (see arrowhead in inset of
Fig. 4X). This indicated that scl and nkx2.5 cooperated in transgene
inhibition in myocardial progenitor cells. To quantify the degree of
co-localization of myl7 and respective transgene signals in control
and morphant cardiac discs, we applied scatter plot analysis on the
digitally reconstructed specimen (Fig. S6) in Volocity software.
Scatter plots from green (c3 and c2 transgenes) and red (myl7)
channels were generated from raw data of acquired z-stacks.
Background correction in the region of interest (ROI i.e. cardiac
disc, schematically indicated by blue dashed circles) resulted in
threshold scatter plots enabling the calculation of co-localization
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(Mred,Mgreen) and overlap (R) coefﬁcients. For the c3 transgene, the
overlap was maximal in the control morphant with R¼77% and
83% of red pixels colocalizing with green pixels (Mred) and 72% of
green pixels colocalizing with red pixels (Mgreen) in the cardiac disc
ROI. In the scl morphant, the decrease in overlap between red and
green channels (R¼53%) and colocalization coefﬁcients
(Mred¼65%, Mgreen¼50%) indicated that the increase in c3 trans-
gene expression occurred in myl7- “endocardial” cells of the scl
morphant cardiac disc. This ﬁnding was supported by the mor-
phology of and central location of upregulated c3 transgene
expression in the scl morphant cardiac disc (Fig. 4D–F), and is
consistent with the reported observations in scl/tal1 mutant
zebraﬁsh (Bussmann et al., 2007). According to our quantiﬁcation
of morphant embryo counts (Fig. 3D), the nkx2.5morphant cardiac
disc also displayed an increase in c3 transgene expression. How-
ever, the overlap and colocalization coefﬁcients decreased only
slightly compared to the control, and Mgreen (i.e. the percentage of
c3þ signal colocalizing with myl7þ signal in the ROI) remained
similar to the control (66% and 72%, respectively, as opposed to 50%
and 72% for the scl knockdown), supporting the notion that myl7þ
“myocardial” cells were the source of increased c3 transgene expres-
sion in nkx2.5 morphants. A further reduction in colocalization and
overlap coefﬁcients in the scl/nkx2.5 double morphant was consistent
with further increased c3 reporter expression according to our
quantitation results (Fig. 3D). In contrast to a trend in reduction of
colocalization and overlap coefﬁcients for the c3 transgene, we noticed
a general trend towards an increase in colocalization between c2
transgene and myl7 signals upon both single scl and combined scl/
nkx2.5 knockdown. Single nkx2.5 knockdown however had no effect
on colocalization coefﬁcients as compared to control morphant
cardiac disc, supporting the idea that the role of nkx2.5 in etv2
inhibition is scl-dependent. In support of a previous report showing
that endothelial speciﬁcation overrides cardiac potential (Schoenebeck
et al., 2007), we could not ﬁnd any colocalization of endogenous etv2
and myl7 signals in double scl/nkx2.5 morphant discs (data not
shown). It is also noteworthy that cells outside the cardiac disc that
Fig. 4. Spatial changes in intron-less c3 and intron-containing c2 transgene expression in scl/nkx2.5 morphant cardiac discs. Display of myl7þ myocardial progenitor cells
(red) and concomitant display of cells expressing either c3 kaedeþ (A–L) or c2 egfpþ (M–X) reporter transgenes (green) by two-color ﬂuorescent in-situ-hybridization.
Merged images are shown in (C, F, I, L) and (O, R, U, X), respectively, with insets showing transverse optical sections at the section plane indicated by dashed lines. In control
embryos, the c3 transgene expression shows maximal overlap with the ﬂat and disc-shape myocardial myl7þ expression domain (A–C, similar as in Fig. S2M–O), but the c2
transgene expression marking the endocardial domain (dashed circle in N) shows minimal overlap (M–O). In sclmorphants, the endocardial domains of both c3 (D–F) and c2
(P–R) transgenes were enlarged (indicated by arrow in F and dashed circle in Q), resulting in compaction of the myocardial domain around the enlarged endocardial domain
(see insets). In nkx2.5 morphants, the size of the myocardial disc was reduced (compare G and S to A and M), however the myocardial c3 transgene expression domain (G–I)
was increased (dashed circle in I). The size of the endocardial domain marked by the c2 transgene was unchanged in nkx2.5 morphant cardiac discs (S–U, dashed circle in T).
In double scl/nkx2.5 knockdown embryos, cardiac expression of the intron-less c3 transgene was increased in both endocardial and myocardial domains (J–L), and intron-less
c2 transgene expression showed an increase in the endocardial domain (V–X). Note myl7þ c2 transgene expressing cells in scl/nkx2.5 double morphants indicated by
arrowhead in the transverse optical section in inset of X. Approximate myocardial domain sizes are given in A, M, G and S. Embryos are 20–22 som in dorsal views with
anterior to the top from one c3 line (F5 generation) and one c2 line (F4). Images shown are snapshots from 3D views with bars E100 μm in relation to the background grid
(1 unit¼45.18 μm). Transverse optical sections (insets) were scaled down 0.6 .
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are transgene-derived are also affected especially by scl knockdown
(Fig. 4E and Q), which supports the previous reported role for Scl in
these vascular-derived structures (Gering et al., 2003; Patterson et al.,
2005).
Taking the quantitative and co-localization data from the
knockdown analysis of c2 and c3 transgene expression together,
the results unambiguously point to scl and nkx2.5 functioning as
repressors of cardiac disc transgene (etv2) expression in cells
destined to enter cardiac lineage at or after 6 som, and maintain-
ing this repression at least until 22 som.
Modulation of scl and nkx2.5 affects endogenous etv2 expression in
endocardial precursors
We next investigated whether scl and nkx2.5 combined knock-
down will affect endogenous etv2 endocardial expression at
cardiac disc/cone stages (Fig. 5). Indeed, scl/nkx2.5 double knock-
down embryos (Fig. 5A and B, p¼0.045, n¼91) showed more
strong etv2 expression compared to scl (Fig. 5B) single knockdown
morphants. The majority of the etv2 expression modulation was
however caused by scl knockdown since nkx2.5 knockdown alone
did not alter etv2 expression signiﬁcantly (Fig. 5B, p¼0.71, n¼122
compared to std.ctrl-MO injection), thus correlating with intron-
containing c2 transgene knockdown responsiveness (Fig. 3E–H).
This indicated that the c2 transgene contained additional critical
regulatory sequence to recapitulate the endogenous etv2 expres-
sion pattern than the unregulated c3 transgene. Taking the
transgene and etv2 expression modulation data together, we
conclude that scl and nkx2.5 are critical regulators of etv2 expres-
sion in the developing zebraﬁsh heart.
Etv2 intronic regions contain both repressive and enhancing cis-
regulatory elements
To assess the contribution of sequence downstream of the
transcription start site to etv2 transcriptional regulation, we
sought to quantify the etv2 promoter activity using dual-
luciferase reporter assays. A series of constructs were designed,
and is shown in Fig. 6A. To examine the inﬂuence of downstream
sequence on promoter activity, we generated ﬁreﬂy luciferase-
based reporter constructs harboring intron-less (c3) and intron-
containing (c2) etv2 promoter fragments (Fig. 6A, c3 and c2).
To exclude the effects of distance between the upstream promoter
fragment and luciferase translation initiation region affecting
reporter expression, we generated a control reporter construct
that contained the downstream sequence in antiparallel orienta-
tion [c2(E1-I2)/anti]. After microinjection into zebraﬁsh zygotes,
luciferase activity was assayed from whole zebraﬁsh embryo
lysates both at 6 and 22 somite stages (Fig. 6B) to compare the
impact of downstream sequence on etv2 promoter activity in early
versus late cardiovascular progenitor cells. Also, we analyzed
promoter activity in a rat myocardium cell line (H9C2) post
transfection of the constructs (Fig. 6B). Constitutive Renilla lucifer-
ase expression driven by a weak thymidine kinase promoter
served as an internal standard to normalize for transgenesis and
transfection efﬁciency, respectively, and was co-injected or trans-
fected with the respective ﬁreﬂy reporter constructs. Statistically
signiﬁcant differences in expression were calculated using t-tests.
We observed that the intron-less c3 reporter showed high expres-
sion in zebraﬁsh embryos at both 6 and 22 somwithout signiﬁcant
difference in time points (p¼0.214). Relative to the empty vector,
this upstream zebraﬁsh etv2 promoter fragment strongly induced
reporter expression about 1000-fold (Fig. 6B, c3–6 som and
22 som). Surprisingly, this fragment was also highly activated in
mammalian embryonic myocardium cells, although one order of
magnitude lower than in zebraﬁsh embryos (Fig. 6B, c3-H9C2).
Because we observed ectopic activation of the analogous GFP
reporter speciﬁcally in myocardial cells of the zebraﬁsh cardiac
disc [Fig. 1 and S2 (co-expression data)], this indicated functional
and speciﬁc conservation of the intron-less etv2 promoter activity
in embryonic myocardium across species. The presence of down-
stream sequence resulted in strong reduction in reporter expres-
sion for the c2 reporter in both zebraﬁsh embryos (100-fold) and
rat H9C2 cells (10-fold) (Figs. 6B, c2). Comparing 6 and 22 som
stages, there was signiﬁcantly more inhibition at 6 som than at
22 som for the c2 reporter (p¼0.017) indicating higher degree of
repression of etv2 promoter activity at 6 som in zebraﬁsh. In the
control situation where the downstream sequence was placed in
antiparallel orientation [Fig. 6B, c2(E1-I2/anti)], the difference in
reporter expression between 6 and 22 som disappeared (p¼0.900)
indicating that temporal aspects of promoter activity were deregu-
lated, and that the inhibition of the etv2 promoter was dependent
on the correct spatial orientation of putative cis-regulatory ele-
ments located in intronic downstream regulatory sequence. Strik-
ingly, the c2(E1-I2/anti)-reporter displayed signiﬁcantly less
expression than the c2 reporter (p¼0.004) in H9C2 cells (Fig. 6B,
c2(E1-I2/anti) – H9C2) further supporting the notion that proper
inhibition of promoter activity by downstream sequence was
dependent on the spatial arrangement of regulatory elements in
that sequence, and on the cellular context rather than simply the
distance formed by nucleotides between the upstream promoter
and translation start site of the reporter. Similarly, the expression
of the c2(E1-I2/anti)-reporter was less than the c2-reporter at the
22 somite time point in zebraﬁsh [Fig. 6B, (n)]. Due to the in vivo
Fig. 5. Response of endogenous etv2 expression to single and combined knock-
downs of nkx2.5 and scl in the cardiac disc: (A) representative embryos showing
categories of etv2 expression in the endocardial domain of the cardiac disc
following single and combined knockdowns of scl and nkx2.5 and quantiﬁcation
in (B). Note that single nkx2.5 morpholino knockdown resulted in no signiﬁcant
modulation of etv2 expression but further increased the effect of scl morpholino in
double knockdown experiments. Embryos shown are at 20–22 som stages in dorsal
view with anterior to the top. *** indicates pr0.001; ** indicates pr0.01;
* indicates pr0.05, n.s.¼not signiﬁcant (p40.05); n.d.¼not detected;
MO¼morpholino; n¼number of scored embryos; blue frame marks the endocar-
dial cardiac disc expression domain of etv2. Categories of transgene expression
magnitudes scored are color-coded in (B).
M.-O. Schupp et al. / Developmental Biology 393 (2014) 71–8378
nature of experiments using microinjections and analysis of
heterogeneous whole embryo lysates as compared to homogenous
H9C2 lysates, we think that this decrease was signiﬁcant, although
the t-test calculation showed this to be closely insigniﬁcant
(p¼0.068). In contrast, clearly no difference in promoter inhibition
was observed between c2 and c2(E1-I2/anti) at 6 som (p¼0.424),
suggesting that the degree of etv2 promoter inhibition was less
ﬂexible at early compared to late somitogenesis stages.
To eventually show that etv2 promoter inhibition was inde-
pendent of downstream sequence length, we replaced the down-
stream sequence by a neutral sequence that was putatively devoid
of regulatory elements (Fig. 6C). We selected combined protein
coding sequence for ampicillin and kanamycin ampliﬁed from the
pCR2.1-TOPO vector (Life Sciences) and cloned it in antiparallel
orientation between the upstream c3 promoter fragment and the
luciferase translation start (Fig. 6A). Unexpectedly, replacement of
the whole downstream region [c2-R(E1-I2)] resulted in similar
reduction of reporter activity like the c2(E1-I2/anti)-reporter
(Fig. 6B) with loss of difference in reporter expression between
6 and 22 somite (Fig. 6C, p¼0.155, compared to difference in
expression between these time points for c2 in this line of
experiments with p¼0.0098). This suggested that either the
sequence length indeed played a role in general repression of
the upstream etv2 promoter region, or the replacement sequence
was not as neutral as expected. To address these questions,
we consecutively replaced both introns in the etv2 down-
stream region by ampicillin/kanamycin coding sequence. Selective
replacement of intron 1 [c2-R(I1)] resulted in clearly evident
difference in expression between 6 and 22 som (Fig. 6C,
p¼0.0002). No difference in reporter expression was observed at
6 som (p¼0.1023), however, expression at 22 som increased two-
fold on average (p¼0.0075), both compared to the c2 reporter,
indicating the presence of an inhibitory element located in intron
1, and that the element was inactive at 6 som. This result
correlated with our previous observations that the absence of
downstream sequence in the c3 (Kaede) reporter did not result in
ectopic expression in myocardial (nkx2.5þ) progenitor cells at the
6–8 som stage (Fig. S2), and the inability to signiﬁcantly increase
c3 reporter expression by scl/nkx2.5 knockdown in endothelial
progenitor cells in the ALPM at 6–8 som (Fig. S3A and B). Selective
replacement of intron 2 [c2-R(I2)] surprisingly resulted in almost
complete absence of luciferase reporter expression at both 6 and
22 som stages compared to c2 (Fig. 6C). These data indicated the
existence of an enhancer element in the second intron of etv2. To
investigate whether regulatory properties of etv2 downstream
sequence were conserved in a heterologous promoter context,
we utilized the zebraﬁsh myl7 promoter, which was previously
described in detail (Huang et al., 2003). Another series of con-
structs was generated as depicted in Fig. 6D. We cloned the
downstream etv2 sequence in forward (myl7þ(E1-I2)) and anti-
parallel (myl7þE1-I2/anti) orientation to the 30end of the myl7
promoter and assayed luciferase activity in whole embryo lysates
24 h after microinjection (Fig. 6E). Themyl7 promoter alone (myl7)
induced luciferase expression around 8-fold relative to the empty
Fig. 6. etv2 and myl7 promoter activity using dual-luciferase reporter assays in zebraﬁsh embryos and cardiac cell line: (A) cartoon of etv2 promoter constructs designed for
dual-luciferase reporter assays in embryos and cell line is depicted. Anti: antiparallel, E: exon, I: intron, R: replacement. (B) Relative luciferase expression for constructs c2, c3
and c2(E1–I2/anti) in 6 and 22 somite embryos and H9C2 cardiac cell line is shown. (C) Relative luciferase expression for etv2 constructs c2, c2-R(E1–I2), c2-R(I1) and c2-R
(I2) in 6 and 22 somite embryos is shown. (D) Cartoon of myl7 promoter constructs designed for dual-luciferase reporter assays in embryos and cell line is depicted. Anti:
antiparallel, E: exon, I: intron, R: replacement. (E) Relative luciferase expression for myl7 constructs myl7, myl7 plus etv2 downstream sequence (E1–I2), and myl7 plus etv2
downstream sequence in antiparallel orientation (E1–I2/anti) in 24 hpf embryos is shown. (F) Relative luciferase expression for myl7 constructs myl7, myl7 plus etv2
downstream sequence in antiparallel orientation (E1–I2/anti), myl7 plus ampicillin/kanamycin sequence [R(E1–I2)], myl7 plus etv2 downstream sequence with intron
1 replacement [R(I1)], myl7 plus etv2 downstream sequence with intron 2 replacement [R(I2)], and etv2 intron 2 placed upstream of the myl7 promoter (I2þmyl7) in 24 hpf
embryos is shown. For panels B, C, E and F, statistical analysis using t test was performed across sample groups. Error bars indicate standard deviations. #: expression relative
to empty vector, þ: expression relative to myl7 promoter. *** Denote pr0.001; ** denote pr0.01; * denotes pr0.05, n.s.¼not signiﬁcant (p40.05).
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vector, however the presence of the downstream sequence did not
cause any change inmyl7 promoter activity. Surprisingly, when the
sequence was attached in the antiparallel orientation, reporter
expression was reduced about 3-fold (p¼0.003) (myl7þ(E1-I2),
Fig. 6E). This indicated that the degree of inhibition of myl7
promoter activity was not affected by the insertion of sequence
between the upstream promoter and luciferase translation start,
but rather by the spatial arrangement of regulatory elements
relative to the promoter. This result was consistent for both the
etv2 promoter in myocardial H9C2 cells and the myl7 promoter in
24 hpf embryos indicating that elements in etv2 downstream
sequence could generally inhibit promoter activity. When the
downstream etv2 sequence was replaced by ampicillin/kanamy-
cin-related sequence this inhibitory effect disappeared (myl7-R
(E1-I2), Fig. 6F). However, and in contrast to the etv2 promoter,
selective replacement of intron 1 did not result in de-repression of
myl7 promoter activity [myl7-R(I1)] but rather showed the oppo-
site effect, indicating that the inhibitory element in intron 1 was
inactive in the myl7 promoter context. At this time, we are unable
to explain the inhibitory feature of etv2 downstream sequence in
antiparallel orientation in myocardial cells or the myl7 promoter.
Consistent with a further increase in repression of etv2 promoter
activity upon replacement of intron 2 [c2-R(I2), Fig. 6C], myl7
promoter activity was also almost completely diminished [myl7-R
(I2), Fig. 6F], which again indicated the presence of an enhancer
element in intron 2. To assess this possibility, we placed the
isolated intron 2 fragment upstream of the myl7 promoter and
observed around two-fold increase in myl7 promoter activity
(Fig. 6F). This result was consistent with a similar increase in
etv2 promoter activity following replacement of intron 2 [Fig. 6C,
c2-R(I2)], thus conﬁrming general promoter enhancing activity in
intron 2.
Taking all results of luciferase assays together, the data suggest
that at least two cis-regulatory elements control the expression of
etv2: one element located in intron 1 is important for inhibition of
etv2 at cardiac disc/cone stages, and intron 2 contains another
element providing positive input into the locus to support etv2
expression during both early and late somitogenesis stages.
Scl binds to zebraﬁsh etv2 proximal promoter DNA in vitro
Since scl knockdown resulted in an increase in both intron-less
and intron-containing reporter transgene as well as endogenous
etv2 expression in heart progenitor cells, we investigated whether
Scl directly binds to the etv2 promoter. Several putative
consensus-binding sites (E-boxes) for bHLH transcription factors
were found in the etv2 promoter region using MatInspector
binding site prediction software. Binding sites for NKX transcrip-
tion factor proteins ﬂank an E-box (281 to 276 relative to the
transcription start site of etv2) (Fig. S1C). It is well established that
Scl binds to its cognate DNA targets in heterodimeric complexes
with class A bHLH proteins E12 and E47 (Hsu et al., 1994) products
of the tcf3 gene in zebraﬁsh. We performed electromobility shift
assays (EMSA) to assess the possibility that Scl binds to the
predicted E-box motif (Fig. 7). Scl and Tcf3 proteins were produced
in reticulocyte-based TNT lysate with PCR-generated DNA tem-
plates (Fig. 7A). Both proteins were FLAG-tagged and co-expressed
in TNT lysate (ST-lysate in Fig. 7B). Western blot was performed to
conﬁrm protein expression using anti-FLAG antibody (left lane in
Fig. 7A, compare to single expressions on the right side of the
marker lane). TNT-lysates were incubated with radioactively end-
labeled dsDNA probes containing the E-box motif (WT probe).
After separation in a non-denaturing polyacrylamide gel, an
additional band was detected (lane 3, indicated by black arrow-
head), which was absent after incubation of the WT probe and
lysate processed with water instead of PCR template (W-lysate in
Fig. 7B, lane 2) or WT probe incubated in binding buffer only
(lane 1). This indicated that in-vitro-translated Scl and Tcf3
proteins bound the E-box motif DNA. To determine if the forma-
tion of this protein-DNA complex was sequence-speciﬁc, competi-
tion assays were performed. The presence of increasing amounts
of unlabeled WT probes (WT competitor, 200 and 540 ng, lanes
4 and 5, respectively) in the binding reaction resulted in a dose-
dependent decrease in complex detection. The display of complex
formation was almost abolished after the addition of 540 ng WT
competitor to the binding reaction. In contrast, increasing equiva-
lent amounts of competitor DNA containing a mutated E-box motif
(transversions) only had a minimal effect on complex formation
(mut competitor, lanes 6 and 7), and the complex was still clearly
visible after addition of 540 ng mutant competitor (lane 5 com-
pared to 7). Complex formation was absent using a labeled mutant
probe with either with ST-lysates (lanes 8 and 9) or W-lysates
(lanes 10 and 11). Note the formation of unspeciﬁc complexes by
undeﬁned lysate components whose intensities were not affected
by the addition of competitor DNAs (indicated by white stars in
Fig. 7B). Free WT and mutant probes were displayed in absence of
lysate (lanes 1, 12 and 13). The presence of anti-FLAG antibody in
the binding reaction caused the disappearance of the complex in a
supershift assay (Fig. S7, compare lane 5 with lanes 6 and 7,
marked by arrowhead). The intensity of signal in and just below
the loading pockets increased in presence of antibody (Fig. S7,
compare lanes 5 and 6/7, marked by þ and n, respectively)
indicating the supershifted complex in that location. This result
conﬁrmed that recombinantly expressed and FLAG-tagged Scl and
E12/47 proteins interacted with the E-box motif of the probe.
Together, our biochemical data show that Scl and Tcf3 proteins
bind sequence-speciﬁcally to the predicted E-box motif in the
proximal etv2 promoter in vitro, providing evidence for a direct
physical interaction of Scl with the etv2 promoter to inhibit etv2
gene expression in endocardial progenitor cells.
Discussion
In this study, we report the genomic plasticity of the etv2 locus
in that elements within the locus direct tissue-speciﬁc activator
and repressor activities during endocardial and myocardial cell
development. The salient features of this study include the
identiﬁcation of intronic elements in the etv2 genomic locus that
are responsible for repressing etv2 transcription in myocardial and
endocardial precursor cells, the role of Scl and Nkx2.5 transcrip-
tion factors in maintaining this repression, and the plasticity of the
etv2 locus as demonstrated by the identiﬁcation of enhancer and
repressor sequences located in the ﬁrst two introns of etv2.
The current knowledge of how myocardial, endocardial and
endothelial lineages are derived from progenitor cells in zebraﬁsh
embryo is not well understood. Fate-mapping studies have
demonstrated that during early gastrulation, cardiac progenitors
arise from bilateral cell populations of the anterior lateral plate
mesoderm (ALPM). Further, myocardial and endocardial progeni-
tors originate in different spatial regions, and are separated
(Keegan et al., 2004; Lee et al., 1994). The transcription factor
networks that guide this process are poorly understood. Etv2, a
key regulator of vascular endothelial cell differentiation is
expressed in endothelial and endocardial but not in myocardial
cells (Proulx et al., 2010). This suggests that the regulation of etv2
expression in progenitor cells is likely to inﬂuence subsequent
steps of cardiac lineage differentiation. We cloned upstream
genomic elements in the etv2 locus that might be responsible
for this regulation, and noticed a clear difference in the reporter
expression between two transgenic lines, one harboring an intron-
containing element (c2) and an intron-deleted element (c3). c2
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and c3 reporters co-localize with endogenous etv2 expression
until 8 som but at some point in between 8 and 20 som, we notice
c3 expression switches into myocardial progenitors. If this switch
in reporter expression is functionally related to the loss of
repressor element in the intron sequence, our results imply that
cells of myocardial and endocardial lineages are plastic between
8 and 20 som stages. Previous data has suggested that etv2 is
never expressed in myocardial progenitor cells and the two
lineages have already separated at the one-somite stage when
the etv2 expression is initiated within the ALPM (Palencia-Desai et
al., 2011). Our results are consistent with this interpretation in that
etv2 expression is repressed in myocardial progenitor cells. How-
ever, the timing of separation of these lineages is not consistent
with our ﬁndings, which is more accurately determined with RNA
expression analysis as performed here compared to GFP protein
ﬂuorescence analysis (Palencia-Desai et al., 2011). Beyond 22 som,
the c2 reporter mimics the endogenous etv2 expression pattern
and is not detectable after 36 hpf, while the c3 reporter continues
to express in the zebraﬁsh heart at 40 hpf and beyond indicating
both a spatial and temporal misregulation of the transgene (Fig.
S3). The data from luciferase-based promoter analysis provide
additional supportive evidence in that a critical cis-regulatory
element resides in etv2 intronic sequence. This element most
likely complement elements in promoter sequence located
upstream of the TSS, and is dispensable at 6 som but essential at
22 som in repressing the reporter. Collectively, these results
suggest that post 8 som and before 20 som, the etv2 expression
is repressed in a select group of cells, which may retain bipotential
(endocardial and myocardial lineage) ability. Studies in zebraﬁsh
that show vessel and blood speciﬁcation overriding cardiac poten-
tial in ALPM (Schoenebeck et al., 2007) support the multipotential
nature of cardiac precursor cells.
What is the mechanism of etv2 repression in cardiac progenitor
cells? Cardiac-speciﬁc transcription factors Nkx2.5, Gata5, and Scl
are likely to participate in this mechanism. Nkx2.5 is one of the
earliest markers of myocardial differentiation, and is observed in
bilateral ALPM as early as 10 som stage (Goldstein and Fishman,
1998), and these cells merge in the midline at 20 som. Knocking
down nkx2.5 and scl in tandem clearly induces reporter transgene
expression in both c2 and c3 transgenic lines, with a statistically
signiﬁcant increase in c3 (Fig. 3D, p¼2.746e-007) compared to c2
transgene expression. Interestingly, the identities of cell types that
express the reporter transgene in these double knockdowns
provide some insight. In the c3 line, combined knockdown of scl
and nkx2.5 increased c3 transgene expression in both myo- and
endocardial progenitor domains (Fig. 4J–L). In the c2 line, reporter
gene expression was increased in endocardial cells as in scl single
knockdown embryos, however when nkx2.5 was knocked down
concomitantly (Fig. 4V–X), we detected myl7þc2 reporter co-
expressing cells (see arrowhead in inset of Fig. 4X) indicating that
scl and nkx2.5 cooperated in transgene inhibition in myocardial
progenitor cells. More importantly, nkx2.5 and scl modulate
endogenous etv2 expression in the endocardium at 20 som. Taken
together, this argues for a previously unappreciated role for nkx2.5
to act as a functional repressor of the etv2 locus perhaps in
putatively myocardial leaning progenitor cells after initial speciﬁ-
cation events. Further, this repressive function of nkx2.5 is scl-
dependent, since nkx2.5 knockdown alone did not signiﬁcantly
alter c2 transgene or endogenous etv2 expression. However, nkx2.5
knockdown alone did alter c3 transgene expression, which is most
likely explained by the lack of critical regulatory sequences in c3
that is required for prevention of ectopic etv2 activation in the
myocardial lineage by nkx2.5 or downstream effectors. Whether
transcriptional changes alone in etv2 locus or alternative hypoth-
esis such as cell fate changes in nkx2.5 knockdown embryos
explains the observed effect remains to be decided. Nkx2.5 knock-
down may indeed alter cell fates early based on recent publication
indicating that nkx2.5 (and nkx2.7) is required to maintain ven-
tricular versus atrial myocardium identities following initial spe-
ciﬁcation of precursor populations (Targoff et al., 2013).
Consistently, in nkx2.5 knockdown embryos, we do not observe
signiﬁcant increase in c3 or c2 expression at 6–8 som. In contrast,
in later embryos (22 som), nkx2.5 loss in c3 (intron-less line)
clearly showed increased c3 expression in cardiac (Fig. S4A) and
Fig. 7. Recombinant Scl protein bound to an E-box motif in the etv2 proximal promoter: (A) detection of in-vitro-translated FLAG-tagged Scl and Tcf3 proteins by western
blot. Co-expressed (left) and single-expressed (right) proteins are shown. (B) Lysates that contained coexpressed proteins (ST; lanes 3–9) or unprocessed lysates (W; lanes 2,
10, 11) were incubated with radiolabelled probes harboring either the wildtype (WT; lanes 1–7) or mutated (mut; lanes 8–13) E-box motif in the presence of increasing
amounts of either wildtype or mutated competitor DNA (WT comp., lanes 4 and 5; mut comp., lanes 6 and 7; 200 and 540 ng, respectively). After non-denaturing gel
electrophoresis and autoradiography, an E-box motif-speciﬁc complex (position indicated by black arrowhead) was detected when ST lysate was used (lanes 3–7) and
disappeared when WT competitors were present (lanes 4 and 5). Mutated competitor DNA had only minimal effect on complex formation (lanes 6 and 7). This complex was
not detected using mutated probes (lanes 8–11). Free probes were displayed without lysates (lanes 1, 12 and 13). White stars indicate non-speciﬁc complexes.
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also head vessel progenitors (Fig. S4B) but minimal effects were
observed in posterior vessel progenitors (Fig. S4C). This suggests
selectivity in Nkx2.5's effects on cell populations at LPM. A cell-
autonomous role for Nkx2.5 in establishing gene-expression
borders within myocardial populations via Notch pathway has
been shown recently (Nakashima et al., 2014). Our data that loss of
nkx2.5 function lead to increased c3 expression in nkx2.5 negative
head vessel progenitor cells may even point to a non-cell auton-
omous role for Nkx2.5 in maintenance of LPM-derived cardiac and
endothelial lineages. However, Nkx2.5's function in a common
progenitor cell cannot be fully excluded. From a transcriptional
mechanism standpoint, the downstream intronic etv2 sequence
functions later, and is essential to limit etv2 expression in anterior
LPM-derived structures. This is based on results from co-
expression (Figs. 2, S2 and 4), knockdowns (Figs. 3, S3 and S4),
and luciferase (Fig. 6) assays. Similar to nkx2.5, knocking down
etv2 and scl together showed more embryos with strong transgene
expression in the cardiac domain (Fig. 3B4, p¼0.004) compared to
knocking down etv2 alone indicating that Scl but not Etv2
regulated c3 transgene expression. Interestingly, previous studies
have shown that knocking down etv2 alone results in abrogation
of trunk LPM scl cells (Sumanas and Lin, 2006) at 6 and 10 som,
implying that Scl–Etv2 transcription factors are dynamically con-
trolling population of cells at LPM with perhaps trunk LPM cells
programmed for vascular fate speciﬁcation, and the ALPM popula-
tion for cardiac speciﬁcation. Collectively, the emerging theme
here is that etv2 expression during cardiac progenitor cell devel-
opment is co-regulated by transcription factor pairs (Scl and Etv2,
Nkx2.5 and Scl), and perhaps Scl plays a critical “molecular switch”
role. This hypothesis would predict that Scl functions as an
activator in vascular cell fate, and a repressor in cardiac cell fate.
Indeed, in mouse Scl represses cardiomyogenesis in prospective
hemogenic endothelium and endocardium (Van Handel et al.,
2012). In scl/tal1 zebraﬁsh mutants, endocardial precursors at
cardiac disc stages show selective defective migration (Bussmann
et al., 2007), and an increase in cdh5þ endocardial cells. Cdh5 is a
putative direct transcriptional target of etv2 (De Val et al., 2008),
and etv2 upregulation in endocardial precursors due to Scl loss-of-
function could explain the increase in cdh5þ cells in this mutant.
These examples and our EMSA data of Scl direct interaction with
the etv2 promoter supports the idea that Scl functions as an etv2
repressor in endocardial progenitor cells. Other factors such as
Gata5 may also participate in this regulation. Gata5 functionally
counteracts the effects of nkx2.5 in the etv2 locus perhaps in
driving cells towards endocardial lineage. Gata5 is known to
function as an activator in cardiogenic precursor cells where it
synergistically works with NF-ATc to activate endocardial tran-
scription (Nemer and Nemer, 2002).
Our data suggests a dynamic etv2 genomic locus that under-
goes changes during the distinct steps of cardiovascular develop-
ment. The intronic cis-regulatory elements in etv2 cooperate with
the upstream promoter region to effectively regulate etv2 expres-
sion in that the elements convey the correct transcriptional output
of etv2 by integration of (nkx2.5-, gata5-mediated) extrinsic and
(scl-, etv2-mediated) intrinsic cues. In turn, these cues control the
responsiveness of etv2 cis-regulatory elements to changing envir-
onments during different stages of cardiovascular development. At
earlier 6–8 somite stages, the spatial arrangement and gene
expression environment of ALPM precursors is substantially dif-
ferent. Here, nkx2.5þ progenitor cells are located in the most
posterior portion of the ALPM, thus still spatially separate from
etv2þ endothelial/endocardial progenitors, scl is robustly
expressed in etv2þ cells, and thus etv2 intronic sequence may
be dispensable to prevent its misexpression in nkx2.5þ progenitor
cells. It is possible that the identiﬁed etv2 intronic elements
become more signiﬁcant when initially speciﬁed endocardial and
myocardial progenitor cells migrate to the embryonic midline and
undergo complex morphogenetic movements during cardiac disc
formation and elongation (Bussmann et al., 2007). During these
stages, inter-cellular signals between endocardial and myocardial
progenitors may be important to dynamically regulate etv2 tran-
scription. Intronic sequence then shields the etv2 locus from
nkx2.5 [and redundant nkx2.7 (Targoff et al., 2013)] function in
myocardial and neighboring progenitors, and Scl directly inhibits
etv2 in endocardial progenitors concomitantly. In addition, activa-
tion of etv2 occurs in endothelial precursors through enhancer
elements up1 [targeted by Foxc transcription factors (Veldman and
Lin, 2012)] and in intron 2 (this study) probably through an ETS
factor mediated positive feedback loop. Consistent with an impor-
tant role for nkx2.5 in establishing gene expression borders
between myocardial-derived linages through the Notch pathway
(Nakashima et al., 2014), it is conceivable that nkx2.5 provides
non-cell autonomous cues that ensure endothelial and cardiac
lineage separation between endocardial and myocardial lineages
during cardiac disc to elongation stages. These Nkx2.5 roles are in
addition to its role in maintenance of ventricular-myocardial
identity. Support to this notion comes from our observation that
loss of nkx2.5 not only increased cardiac, but also head vessel
expression of the c3 transgene. Other mechanisms that may
contribute to etv2 repression include the recent identiﬁcation of
microRNA coding elements in the 30UTR of etv2 (Moore et al.,
2013), which adds another layer of etv2 regulation at this locus.
Future studies will illuminate the details of these seemingly
disparate mechanistic processes, and whether these mechanisms
are amenable to therapeutic manipulations that will beneﬁt
cardiovascular disease.
In summary, this study has identiﬁed novel elements in etv2
cis-regulatory sequence that are partly responsible for mediating
inhibition of etv2 expression via Nkx2.5 and Scl transcription
factors. These elements and factors help maintain the repressive
state of the etv2 genomic locus in cardiac progenitor cells thus
implying the existence of endothelial progenitors with endocardial
and myocardial lineage plasticity and expanding the concept of
cardiogenic endothelium. To our knowledge, this is the ﬁrst report
that links Scl and Nkx2.5 transcription factors in a novel cis-
regulatory repression mechanism during embryonic cardiac devel-
opment of vertebrates.
Conclusions
Recently, the existence of multipotent progenitors of cardiac,
blood and endothelial cell lineages was proposed. Genes essential
for blood and endothelial speciﬁcation were shown to restrict the
cardiac potential of progenitor cells, however, the molecular
mechanisms underlying the separation and maintenance of cardi-
ovascular lineages remain unclear. Here, we identify a cis-
regulatory mechanism controlling expression of etv2, a transcrip-
tion factor essential for endothelial cell identity and shown to
participate in blood and cardiac lineage speciﬁcation decisions
during zebraﬁsh embryonic development. In particular, mechan-
isms preventing etv2 expression in cardiac progenitor cells are
unknown. We identiﬁed etv2 genomic elements precluding etv2
misexpression in cardiac progenitor cells, and this regulation
occurs between 8 and 22 somite stages in the developing zebraﬁsh
embryo. Further we found that scl and nkx2.5, genes important for
blood and cardiac speciﬁcation, work cooperatively to inhibit etv2
expression, and this co-regulation is functionally responsible for
myocardial and endocardial progenitor cell population develop-
ment in the cardiac disc. Our results conﬁrm the recently recog-
nized developmental plasticity of cardiovascular progenitor cells
during development.
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